Stemline Targeting cancer at its root
developing novel drugs that attack Cancer Stem Cells

SEC Filings

SEC Filings

There are no SEC filings available.

Copyright Morningstar



Copyright 2018 - Stemline Therapeutics, Inc. All rights reserved